Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,958.80
(
1.33%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
92.14
(
3.69%
)
Bitcoin
74,023.25
(
-2.26%
)
News Focus
News Focus
Post# of 57783
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

bladerunner1717

Send PM Follow Ignore
Followers 36
Posts 5652
Boards Moderated 0
Alias Born 11/09/2003

bladerunner1717

Re: Aiming4 post# 11434

Tuesday, 10/16/2007 2:10:50 PM

Tuesday, October 16, 2007 2:10:50 PM

Post# of 57783
Aiming,

I had forgotten that mild cognitive impairment (MCI) was now a definitive disease category with the FDA (in Neurology, gfp). I'm wondering why CX717 (or CX701) hasn't been mentioned by Stoll in relationship to MCI. It might be a better target than AD with a much healthier population. (This could also be considered a drawback, too.) But, I suspect, it would be much easier to recruit.


Bladerunner
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today